North Carolina · 81210

Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1) in North Carolina

North Carolina Medicare Avg
$171.89
0% above national avg
National Medicare Avg
$171.28
All states combined
Billed Charge (NC)
$859.75
What providers submit
Est. Commercial (NC)
$374.72
National avg: $383.66
Est. Cash / Self-Pay (NC)
$365.35
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

79
Services in NC
1
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in North Carolina

Provider Medicare Services
Laboratory Corporation Of America... $171.89 79

North Carolina Pricing in Context

In North Carolina, CPT code 81210 (Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1)) carries an average Medicare payment of $171.89 — 0% above the national benchmark of $171.28. 1 providers across the state submitted claims for this procedure in 2023, performing 79 total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in North Carolina is $859.75, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Urinalysis procedures, the estimated commercial insurance price in North Carolina lands near $374.72, with self-pay cash prices typically around $365.35. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1) cost in North Carolina?

The average Medicare payment for Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1) in North Carolina is $171.89, which is 0% above the national average of $171.28. Providers in NC typically bill $859.75 for this procedure.

What does Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1) cost with insurance in North Carolina?

With commercial insurance in North Carolina, Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1) costs an estimated $374.72. Without insurance, the estimated cash price is $365.35. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1) in North Carolina?

1 providers in North Carolina billed Medicare for Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1) in 2023, performing 79 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1) cheaper in North Carolina than the national average?

No — Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1) costs 0% above the national average in North Carolina. The state average Medicare payment is $171.89 compared to $171.28 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial